151 related articles for article (PubMed ID: 18182738)
1. Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience.
Bonney GK; Gomez D; Rahman SH; Verbeke CS; Prasad KR; Toogood GJ; Lodge JP; Menon KV
JOP; 2008 Jan; 9(1):19-25. PubMed ID: 18182738
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
3. Central pancreatectomy: single-center experience of 50 cases.
Adham M; Giunippero A; Hervieu V; Courbière M; Partensky C
Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
[TBL] [Abstract][Full Text] [Related]
4. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumors: presentation, management, and outcomes.
Nissen NN; Kim AS; Yu R; Wolin EM; Friedman ML; Lo SK; Wachsman AM; Colquhoun SD
Am Surg; 2009 Oct; 75(10):1025-9. PubMed ID: 19886158
[TBL] [Abstract][Full Text] [Related]
6. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
7. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
[TBL] [Abstract][Full Text] [Related]
8. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
9. Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?
Abu Hilal M; McPhail MJ; Zeidan BA; Jones CE; Johnson CD; Pearce NW
JOP; 2009 May; 10(3):276-9. PubMed ID: 19454819
[TBL] [Abstract][Full Text] [Related]
10. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.
Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL
Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374
[TBL] [Abstract][Full Text] [Related]
11. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
[TBL] [Abstract][Full Text] [Related]
12. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.
Schurr PG; Strate T; Rese K; Kaifi JT; Reichelt U; Petri S; Kleinhans H; Yekebas EF; Izbicki JR
Ann Surg; 2007 Feb; 245(2):273-81. PubMed ID: 17245182
[TBL] [Abstract][Full Text] [Related]
13. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
Teh SH; Deveney C; Sheppard BC
Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
[TBL] [Abstract][Full Text] [Related]
14. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
17. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
18. Well or poorly differentiated nonfunctioning neuroendocrine carcinoma of the pancreas: a single institution experience with 17 cases.
Sellner F; Sobhian B; De Santis M; Pont J; Staettner S; Sellner S; Karner J; Klimpfinger M
Eur J Surg Oncol; 2008 Feb; 34(2):191-5. PubMed ID: 17475440
[TBL] [Abstract][Full Text] [Related]
19. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
20. Treatment of locoregional recurrence after intentional curative resection of pancreatic cancer.
Menke-Pluymers MB; Klinkenbijl JH; Tjioe M; Jeekel J
Hepatogastroenterology; 1992 Oct; 39(5):429-32. PubMed ID: 1459525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
